Jun Yin

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 18 papers. Top paper: “Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database”.

Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database

Annals of Oncology(2020)10.1016/j.annonc.2019.12.007

N/A

1.4DataRank · unranked

34 citations

Jun Yin, Richard M. Goldberg, Levi Pederson, Norman Wolmark, Steven R. Alberts +11 more

Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance)

Blood Advances(2021)10.1182/bloodadvances.2021004233

N/A

1.0DataRank · unranked

30 citations

Guido Marcucci, Jun Yin, William Blum, Wendy Stock, Jessica Kohlschmidt +15 more

Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0145

N/A

0.790DataRank · unranked

193 citations

Sonja Bendig, Zhaohui Gu, Xiaolong Chen, Petri Pölönen, Xiaotu Ma +47 more

Results of a phase 3 study of IVO vs IO for previously untreated older patients (pts) with chronic lymphocytic leukemia (CLL) and impact of COVID-19 (Alliance).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.7500

N/A

0.687DataRank · unranked

14 citations

Jun Yin, Jennifer R. Brown, Shira Dinner, Gerard Lozanski, Richard F. Little +15 more

Chemotherapy-free treatment with inotuzumab ozogamicin and blinatumomab for older adults with newly diagnosed, Ph-negative, CD22-positive, B-cell acute lymphoblastic leukemia: Alliance A041703.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.7006

N/A

0.584DataRank · unranked

48 citations

Jun Yin, Oudom Kour, Rebecca Teske, Wendy Stock, Kenneth Byrd +12 more

Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of JAK1/STAT3 and AKT signaling

Cell Reports(2021)10.1016/j.celrep.2021.108765

N/A

0.571DataRank · unranked

44 citations

Wei Hou, Aldeb Perera, Carlee Bettler, Jordan R. Beach, Xianzhong Ding +10 more

Alemtuzumab in frontline therapy of adult acute lymphoblastic leukemia: Results of Cancer and Leukemia Group B 10102 (Alliance), a phase 1/2 study

Cancer(2025)10.1002/cncr.35750

N/A

0.216DataRank · unranked

3 citations

Jun Yin, Gerard Lozanski, Emily Curran, Gregory Malnassy, Krzysztof Mrózek +15 more

Relevance of bone marrow biopsies for response assessment in NCTN follicular lymphoma clinical trials.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8038

N/A

0.104DataRank · unranked

1 citations

Jun Yin, Levi Pederson, Betsy LaPlant, Mazyar Shadman, Hongli Li +15 more

NMR chemical shift assignment of Drosophila odorant binding protein 44a in complex with 8(Z)-eicosenoic acid

Biomolecular NMR Assignments(2024)10.1007/s12104-024-10178-2

N/A

0DataRank · unranked

4 citations

Mary R. Starich, Yi He, Jun Yin, Quan Yuan, Nico Tjandra +1 more

Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma

Blood Advances(2024)10.1182/bloodadvances.2023012090

N/A

0DataRank · unranked

2 citations

Jun Yin, Levi Pederson, Kristie A. Blum, Peter Martin, Sin‐Ho Jung +7 more

Design of a cluster randomized multi-level intervention to decrease barriers to minority cancer patient referral and enrollment to cancer clinical trials: The ACT WONDER2S study

Contemporary Clinical Trials(2025)10.1016/j.cct.2025.108096

N/A

0DataRank · unranked

1 citations

Melany Garcia, Rossybelle P. Amorrortu, Yayi Zhao, Brian S. Mittman, Kea Turner +13 more

Morphological heterogeneity in beta-catenin–mutated hepatocellular carcinomas: implications for tumor molecular classification

Human Pathology(2021)10.1016/j.humpath.2021.09.009

N/A

0DataRank · unranked

23 citations

Chantal E. McCabe, Daniel R. O’Brien, Jun Yin, Tiffany M. Bainter, Nguyen H. Tran +7 more

Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab187

N/A

0DataRank · unranked

16 citations

Mohamed E. Salem, Jesse G. Dixon, Zhaohui Jin, Romain Cohen, Aimery DeGramont +16 more

FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations

Digestive Diseases and Sciences(2021)10.1007/s10620-021-07303-9

N/A

0DataRank · unranked

12 citations

Thomas DeLeon, James M. Bogenberger, Rish K. Pai, Heidi Kosiorek, Jun Yin +26 more

phase1RMD: An R package for repeated measures dose-finding designs with novel toxicity and efficacy endpoints

PLoS ONE(2021)10.1371/journal.pone.0256391

N/A

0DataRank · unranked

3 citations

Yu Du, Rui Qin, Shihao Shen, Sumithra J. Mandrekar, Jun Yin

Cell-Free Tumor DNA Dominant Clone Allele Frequency (DCAF) Is Associated With Poor Outcomes In Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy

medRxiv(2021)10.1101/2021.11.01.21265773

N/A

0DataRank · unranked

0 citations

Umair Majeed, Jun Yin, Gehan Botrus, Mohamad Bassam Sonbol, Daniel H. Ahn +25 more

Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases

npj Precision Oncology(2023)10.1038/s41698-023-00471-z

N/A

0DataRank · unranked

24 citations

Jennifer R. Ribeiro, Jun Yin, Joanne Xiu, Matías A. Bustos, Fumito Ito +17 more

Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts

Leukemia(2024)10.1038/s41375-024-02143-8

N/A

0DataRank · unranked

6 citations

Andrew H. Wei, Sumithra J. Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse‐Chieh Teh +24 more